Encouraging news for those battling hair loss: A leading U.S. company has engineered a wearable cap that stimulates hair regrowth using advanced low-level laser therapy (LLLT). Discreet and convenient, it can be used anywhere, anytime.
A 2015 IFOP survey found that 13% of French people experience baldness—a figure stable over the past 25 years. It also impacts 3% of women aged 65 and older. With nearly one in four French adults affected, many seek effective solutions. For countless individuals, hair loss is emotionally challenging.
U.S.-based Kiier has created the Laser Therapy Cap, a cutting-edge device designed to address androgenetic alopecia. This unassuming cap employs low-level lasers to counteract accelerating hair loss.
Low-level laser therapy (LLLT), the foundation of this cap, dates back to the 1960s when scientist Endre Mester pioneered it. Medical professionals have long used LLLT for hair restoration, with multiple studies confirming its efficacy in promoting regrowth for both men and women.
The Laser Therapy Cap's diodes emit cool, heat-free light that enhances scalp blood circulation, delivering vital nutrients to hair follicles. Available in two models—the Kiier Pro with 148 laser diodes and the Kiier Premier with 272—the company reports up to 93% efficacy, with visible results in 3–7 months.
Cleared by the U.S. Food and Drug Administration (FDA), the device includes a full money-back guarantee if no results appear after seven months. It's suitable for men at Norwood stages II to V (out of VIII) and women at Ludwig stages I and II (out of III), but not for advanced baldness.
